Category: diabetes

1. Overview & Therapeutic Role Abecma represents a pioneering BCMA-targeted CAR T‑cell therapy for adults battling relapsed or refractory multiple myeloma, particularly those who have been treated with immunomodulators, proteasome inhibitors, and anti‑CD38 antibodies. It leverages a patient’s own immune cells to seek and destroy myeloma cells efficiently. Approved by the FDA in March 2021, it…